List of Excipients in API selexipag
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing selexipag
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | CARNAUBA WAX | |
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | FERRIC OXIDE YELLOW | |
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | HYDROXYPROPYL CELLULOSE | |
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | HYPROMELLOSE | |
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | |
| Actelion Pharmaceuticals US Inc | UPTRAVI | selexipag | 66215-602 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for selexipag
Excipient focus: CARNAUBA WAX
selexipag drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
selexipag drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
selexipag drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
selexipag drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
selexipag drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
selexipag drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
selexipag drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
selexipag drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
selexipag drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
selexipag drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actelion Pharmaceuticals US Inc | selexipag | 66215-602 |
| >Company | >Ingredient | >NDC |
selexipag drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
